Johann Peter Morsdorf

Title: Johann Peter Morsdorf: Innovator in Pharmaceutical Chemistry

Introduction

Johann Peter Morsdorf is a notable inventor based in Langenzenn, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his work on polymorphic forms of doxazosin mesylate. With a total of 6 patents to his name, Morsdorf's innovations have had a considerable impact on drug formulation and processing.

Latest Patents

Morsdorf's latest patents include two distinct polymorphic forms of doxazosin mesylate. The first patent describes a new crystalline and anhydrous form (form III) characterized by specific reflex positions in its X-ray spectrum. This form offers surprising advantages in both synthesis and pharmaceutical processing into solid dosage forms. The second patent details another crystalline and anhydrous form (form II), which also presents unique benefits for drug formulation. Both patents emphasize the importance of crystalline properties in enhancing the efficacy of pharmaceutical compositions.

Career Highlights

Throughout his career, Morsdorf has worked with reputable companies such as Heumann Pharma GmbH and U.S. Bioscience, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Morsdorf has collaborated with notable colleagues, including Ingomar Grafe and Paul Edwin Kennedy. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Johann Peter Morsdorf's contributions to pharmaceutical chemistry, particularly through his innovative work on doxazosin mesylate, highlight his role as a significant inventor in the field. His patents reflect a commitment to improving drug formulation and processing, ultimately benefiting the pharmaceutical industry.